Videos / Enteric coated risedronate 35mg for the treatment of osteoporosis
In this Product Explainer, Endocrinologist Prof Ego Seeman explains the role of enteric coated risedronate 35mg for the treatment of osteoporosis (5 mins).

Frozen Shoulder – A Practical Guide to Assessment and Management

Implementing the Four Pillars of Heart Failure Management in GP

PCOS Update

Biologics in COPD – 20% of Your Patients Could Benefit

expert
Endocrinologist; Dept of Medicine and Endocrinology, Austin Health, University of Melbourne; Editor, Progress in Osteoporosis